DXCM - Financial Reports List - DexCom, Inc. - IntrinsicAlpha

DexCom, Inc. DXCM

Healthcare - Medical - Devices - NASDAQ - US

$ 66.33

-3.59 %

$ 26 B

Market Cap

46.56

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	7.64%	-40.81%	-12.91%
Annual Report	FY	10-K	2024-12-31	11.34%	6.41%	0.38%
Quarterly Report	Q3	8-K	2024-09-30	1.97%	11.52%	-26.03%
Quarterly Report	Q2	8-K	2024-06-30	15.26%	23.81%	23.34%
Quarterly Report	Q1	8-K	2024-03-31	24.21%	201.23%	114.19%
Quarterly Report	Q4	8-K	2023-12-31	26.90%	179.19%	72.97%
Annual Report	FY	10-K	2023-12-31	24.49%	58.70%	52.79%
Quarterly Report	Q3	8-K	2023-09-30	26.69%	19.27%	39.32%
Quarterly Report	Q2	8-K	2023-06-30	25.15%	127.70%	66.36%
Quarterly Report	Q1	8-K	2023-03-31	17.92%	-50.05%	14.29%

1